SEPTIN4 and hepatocellular carcinoma: ARTS expression is lost in more than 70% of acute lymphoblastic leukemia (ALL) patients and 50% of lymphoma patients and in a significant fraction of hepatocellular carcinoma (HCC) patients [23, 24].